1. Home
  2. MNKD vs OBK Comparison

MNKD vs OBK Comparison

Compare MNKD & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • OBK
  • Stock Information
  • Founded
  • MNKD 1991
  • OBK 1912
  • Country
  • MNKD United States
  • OBK United States
  • Employees
  • MNKD N/A
  • OBK N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • OBK Major Banks
  • Sector
  • MNKD Health Care
  • OBK Finance
  • Exchange
  • MNKD Nasdaq
  • OBK Nasdaq
  • Market Cap
  • MNKD 1.5B
  • OBK 1.3B
  • IPO Year
  • MNKD 2004
  • OBK 2018
  • Fundamental
  • Price
  • MNKD $5.76
  • OBK $38.33
  • Analyst Decision
  • MNKD Buy
  • OBK Strong Buy
  • Analyst Count
  • MNKD 6
  • OBK 5
  • Target Price
  • MNKD $8.92
  • OBK $44.00
  • AVG Volume (30 Days)
  • MNKD 1.7M
  • OBK 168.0K
  • Earning Date
  • MNKD 02-26-2025
  • OBK 01-22-2025
  • Dividend Yield
  • MNKD N/A
  • OBK 1.53%
  • EPS Growth
  • MNKD N/A
  • OBK N/A
  • EPS
  • MNKD 0.08
  • OBK 2.45
  • Revenue
  • MNKD $267,200,000.00
  • OBK $348,297,000.00
  • Revenue This Year
  • MNKD $44.15
  • OBK N/A
  • Revenue Next Year
  • MNKD $19.65
  • OBK $8.26
  • P/E Ratio
  • MNKD $72.34
  • OBK $16.00
  • Revenue Growth
  • MNKD 51.35
  • OBK 2.10
  • 52 Week Low
  • MNKD $3.47
  • OBK $27.69
  • 52 Week High
  • MNKD $7.63
  • OBK $41.17
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 48.03
  • OBK 50.32
  • Support Level
  • MNKD $5.32
  • OBK $38.94
  • Resistance Level
  • MNKD $5.65
  • OBK $41.17
  • Average True Range (ATR)
  • MNKD 0.18
  • OBK 1.01
  • MACD
  • MNKD 0.03
  • OBK -0.26
  • Stochastic Oscillator
  • MNKD 81.48
  • OBK 33.53

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.

Share on Social Networks: